CA2013087A1 - Derives de carbonate d'eseroline, procede de preparation et utilisation comme medicaments - Google Patents

Derives de carbonate d'eseroline, procede de preparation et utilisation comme medicaments

Info

Publication number
CA2013087A1
CA2013087A1 CA2013087A CA2013087A CA2013087A1 CA 2013087 A1 CA2013087 A1 CA 2013087A1 CA 2013087 A CA2013087 A CA 2013087A CA 2013087 A CA2013087 A CA 2013087A CA 2013087 A1 CA2013087 A1 CA 2013087A1
Authority
CA
Canada
Prior art keywords
eseroline
medicaments
preparation
carbonate derivatives
see formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2013087A
Other languages
English (en)
Other versions
CA2013087C (fr
Inventor
Edward J. Glamkowski
Yulin Chiang
Barbara E. Kurys
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Hoechst Roussel Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharmaceuticals Inc filed Critical Hoechst Roussel Pharmaceuticals Inc
Publication of CA2013087A1 publication Critical patent/CA2013087A1/fr
Application granted granted Critical
Publication of CA2013087C publication Critical patent/CA2013087C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002013087A 1989-03-27 1990-03-26 Derives de carbonate d'eseroline, procede de preparation et utilisation comme medicaments Expired - Lifetime CA2013087C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/329,171 US4971992A (en) 1989-03-27 1989-03-27 Carbonate derivatives of eseroline
US329,171 1989-03-27

Publications (2)

Publication Number Publication Date
CA2013087A1 true CA2013087A1 (fr) 1990-09-27
CA2013087C CA2013087C (fr) 1999-12-28

Family

ID=23284183

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002013087A Expired - Lifetime CA2013087C (fr) 1989-03-27 1990-03-26 Derives de carbonate d'eseroline, procede de preparation et utilisation comme medicaments

Country Status (18)

Country Link
US (1) US4971992A (fr)
EP (1) EP0389984B1 (fr)
JP (1) JPH0737458B2 (fr)
KR (1) KR0163049B1 (fr)
AT (1) ATE124044T1 (fr)
AU (1) AU621208B2 (fr)
CA (1) CA2013087C (fr)
DE (1) DE69020205T2 (fr)
DK (1) DK0389984T3 (fr)
ES (1) ES2075081T3 (fr)
FI (1) FI92932C (fr)
HU (1) HU204053B (fr)
IE (1) IE67449B1 (fr)
IL (1) IL93895A (fr)
NO (1) NO173995C (fr)
NZ (1) NZ233065A (fr)
PT (1) PT93535B (fr)
ZA (1) ZA902307B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4791107A (en) * 1986-07-16 1988-12-13 Hoechst-Roussel Pharmaceuticals, Inc. Memory enhancing and analgesic 1,2,3,3A,8,8A-hexahydro-3A,8 (and) 1,3A,8)-di(and tri)methylpyrrolo(2,3-B)indoles, compositions and use
US4914102A (en) * 1989-09-28 1990-04-03 Hoechst Roussel Pharmaceuticals, Inc. N-aminocarbamates related to physostigmine, pharmacentical compositions and use
US5077289A (en) * 1989-11-30 1991-12-31 Hoechst Roussel Pharmaceuticals Inc. Memory enhancing and analgesic aminocarbonylcarbamates related to physostigmine
US4983616A (en) * 1990-02-01 1991-01-08 Hoechst-Roussel Pharmaceuticals Inc. Hexahydropyrrolo(2,3-B)indole carbamates, ureas, amides and related compounds
US5216017A (en) * 1990-05-11 1993-06-01 Hoechst-Roussel Pharmaceuticals Incorporated Pyrrolo[2,3-b]indole-ketones and analogs
AU634654B2 (en) * 1990-05-11 1993-02-25 Hoechst-Roussel Pharmaceuticals Incorporated Pyrrolo(2,3-b)indole-ketones and analogs, a process for their preparation and their use as medicaments
AU634380B2 (en) * 1990-05-17 1993-02-18 Hoechst-Roussel Pharmaceuticals Incorporated Alpha-oxopyrrolo(2,3-b)indole acetic acids, esters, amides and related analogs, a process for their preparation and their use as medicaments
DE4139763A1 (de) * 1991-12-03 1993-06-09 Kali-Chemie Pharma Gmbh, 3000 Hannover, De Kristalline fumarsaure salze von 9,9-alkylen-3,7-diazabicyclononan-verbindungen und diese verbindungen enthaltende arzneimittel
US5409948A (en) * 1992-11-23 1995-04-25 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Method for treating cognitive disorders with phenserine
AT404907B (de) * 1993-07-13 1999-03-25 Andritz Patentverwaltung Verfahren und anlage zum herstellen von edelstahlband
US5665880A (en) * 1996-10-31 1997-09-09 Hoechst Marion Roussel, Inc. Method of preparation of physostigmine carbamate derivatives from eseretholes
US5677457A (en) * 1996-12-19 1997-10-14 Hoechst Marion Roussel, Inc. Method of preparation of physostigmine carbamate derivatives from eseroline ethers
US20050182044A1 (en) * 2004-02-17 2005-08-18 Bruinsma Gosse B. Combinatorial therapy with an acetylcholinesterase inhibitor and (3aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3,-b]indol-5-yl phenylcarbamate
CA2508585A1 (fr) * 2004-06-01 2005-12-01 Axonyx, Inc. Dispositif d'administration transdermique pour le traitement des troubles cognitifs
US20050272804A1 (en) * 2004-06-08 2005-12-08 Axonyx, Inc Methods of delaying Alzheimer's disease progression using a beta-amyloid precursor protein inhibitor and a HMG CoA reductase inhibitor

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1109003B (it) * 1977-09-20 1985-12-16 Univ Firenze Derivati dell 1 2 3 8 3 a 8 a esai dropirrolo 23 b indolo
US4791107A (en) * 1986-07-16 1988-12-13 Hoechst-Roussel Pharmaceuticals, Inc. Memory enhancing and analgesic 1,2,3,3A,8,8A-hexahydro-3A,8 (and) 1,3A,8)-di(and tri)methylpyrrolo(2,3-B)indoles, compositions and use
US4914102A (en) * 1989-09-28 1990-04-03 Hoechst Roussel Pharmaceuticals, Inc. N-aminocarbamates related to physostigmine, pharmacentical compositions and use
US5077289A (en) * 1989-11-30 1991-12-31 Hoechst Roussel Pharmaceuticals Inc. Memory enhancing and analgesic aminocarbonylcarbamates related to physostigmine

Also Published As

Publication number Publication date
HU204053B (en) 1991-11-28
DE69020205D1 (de) 1995-07-27
IL93895A (en) 1995-07-31
NO901385L (no) 1990-09-28
EP0389984A1 (fr) 1990-10-03
FI92932C (fi) 1995-01-25
JPH0737458B2 (ja) 1995-04-26
HU901832D0 (en) 1990-08-28
NO173995C (no) 1994-03-02
IL93895A0 (en) 1990-12-23
ZA902307B (en) 1990-12-28
KR900014388A (ko) 1990-10-23
NZ233065A (en) 1992-04-28
ATE124044T1 (de) 1995-07-15
AU621208B2 (en) 1992-03-05
PT93535B (pt) 1996-03-29
ES2075081T3 (es) 1995-10-01
CA2013087C (fr) 1999-12-28
KR0163049B1 (ko) 1998-12-01
NO173995B (no) 1993-11-22
DE69020205T2 (de) 1995-12-07
DK0389984T3 (da) 1995-10-30
IE901097L (en) 1990-09-27
EP0389984B1 (fr) 1995-06-21
FI92932B (fi) 1994-10-14
PT93535A (pt) 1990-11-07
JPH02289572A (ja) 1990-11-29
HUT54159A (en) 1991-01-28
AU5220290A (en) 1990-11-08
IE67449B1 (en) 1996-04-03
NO901385D0 (no) 1990-03-26
US4971992A (en) 1990-11-20
FI901470A0 (fi) 1990-03-23

Similar Documents

Publication Publication Date Title
CA2029265A1 (fr) Derives 4- et 6-carbamate de physostigmine; methode et produits intermediaires pour leur preparation, leur utilisation comme medicaments
CA2013087A1 (fr) Derives de carbonate d'eseroline, procede de preparation et utilisation comme medicaments
AU3544593A (en) New naphthylalkylamines, process for preparing them and pharmaceutical compositions containing them
HUT68029A (en) New 11-benzaldoxim-estradiene derivatives, pharmaceutical compositions containing them and process for producing them
CA2059103A1 (fr) Methode de preparation de (6s)- et (6r)-tetrahydrofolates
AU636351B2 (en) N-heteroaryl-purin-6-amines, a process for their preparation and their use as medicaments
AU4616893A (en) New benzopyran compounds, process for their preparation and the pharmaceutical compositions which contain them
CA2031079A1 (fr) Aminocarbonylcarbamates apparentes a la physostigmine, un procede pour les preparer et leur utilisation comme medicaments
HUT68315A (en) New 11-benzaldoxime-17-beta-methoxy-17-alpha-methoxy-methyl-estradiene derivatives, pharmaceutical compositions containing them and process for producing them
GR3017599T3 (en) Thiochromane derivatives, process for their preparation and pharmaceutical compositions containing them.
IE891578L (en) Compounds with central analgesic activity, process for their¹preparation and pharmaceutical compositions containing them
AU4204793A (en) New aminoalkylchromones, processes for the preparation thereof, and pharmaceutical compositions containing them
AU659738B2 (en) New pyrrolothienopyrazine compounds, processes for the preparation thereof, and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry